bret michaels drops bombshell, pivots poison empire into multi-billion dollar health tech startup
The rock icon turns his near-fatal diabetes battle into a disruptive MedTech IPO, targeting a $4.2B valuation by 2026 and forcing Wall Street to recalibrate celebrity-backed venture models.